Products

Segmentron Viewer
DGNCT LLC
Dental AI
Segmentron Viewer is an FDA-cleared, AI-powered semi-automated software as a medical device (SaMD) for dental image processing and management, providing 3D segmentation and visualization of maxillofacial CBCT images for medical professionals.

See all 1 product →

About DGNCT

DGNCT LLC, operating under the trade name Diagnocat, is a healthcare AI company specializing in advanced dental diagnostics. Their award-winning AI-powered software analyzes various dental imaging formats, including panoramic radiographs (PRs), intraoral images, and cone beam computed tomography (CBCT) scans. The system is designed to assist dental professionals in identifying a wide range of conditions, such as dental caries, existing restorations, missing teeth, periodontal bone loss, and periapical radiolucency, often highlighting areas of potential concern with visual alerts.

For physicians, Diagnocat serves as an intelligent second opinion, aiming to enhance diagnostic precision, mitigate diagnostic errors linked to examiner fatigue, and reinforce clinical decision-making. It streamlines workflows by automating image analysis and generating detailed, easy-to-understand reports, which also aid in patient education and communication regarding treatment rationale. The platform is FDA-cleared and adheres to high standards of data security, including HIPAA and SOC 2 compliance, ensuring a reliable and secure tool for modern dental practice.

Focus Areas

AI-powered dental imaging analysis diagnostic support 2D and 3D dental image processing automatic segmentation 3D visualization radiological reports patient education treatment planning detection of dental conditions

Business Intelligence

PartnershipsSirona, Vatech, Planmeca, Carestream (CBCT system integrations)
TechnologyCloud-based software, web application, Convolutional Neural Networks (CNNs), deep learning models (U-Net-like and Mask R-CNN architectural models)
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

AI-Powered Analysis & Detection
DGNCT specializes in advanced AI-powered dental imaging analysis for precise and rapid detection of various dental conditions, enhancing diagnostic accuracy and efficiency.
Comprehensive Image Processing
Offers robust 2D and 3D dental image processing capabilities, including automatic segmentation of anatomical structures and high-fidelity 3D visualization for detailed examination.
Diagnostic Support & Reporting
Provides critical diagnostic support tools and generates comprehensive radiological reports, aiding physicians in informed clinical decision-making and documentation.
Treatment Planning & Patient Education
Facilitates sophisticated treatment planning with visual aids and offers intuitive patient education tools, improving patient understanding and acceptance of proposed treatments.
Key Differentiators
DGNCT's primary differentiator is its integrated, end-to-end AI-first approach, covering the entire dental imaging workflow from raw image to diagnosis, planning, and patient communication. The combination of automatic segmentation, 3D visualization, and AI-driven detection within a single platform offers unparalleled efficiency, accuracy, and a holistic view for dental professionals.
Technology Stack (Inferred)
Leverages cutting-edge Artificial Intelligence (AI) and Machine Learning (ML) algorithms for analysis and segmentation, advanced Computer Vision techniques for 2D/3D image processing, and sophisticated 3D rendering technologies, likely deployed on a scalable cloud infrastructure for accessibility and performance.
Physician Tip

For physicians, DGNCT significantly streamlines the diagnostic workflow by automating time-consuming tasks like image segmentation and condition detection, allowing for more focus on patient care. The AI-powered insights enhance diagnostic confidence and accuracy, potentially leading to earlier intervention and improved patient outcomes. The integrated 3D visualization and patient education tools are invaluable for clear communication, fostering greater patient trust and treatment plan acceptance. This comprehensive solution empowers dentists to practice with greater precision, efficiency, and patient engagement.

While specific integrations are not detailed, a comprehensive platform like DGNCT would typically offer seamless integration capabilities with existing Practice Management Software (PMS), Electronic Health Records (EHR) systems, and various Digital Radiography (DR) equipment to ensure a smooth and uninterrupted workflow within a dental practice.

Products by DGNCT

1 product in the directory

Segmentron Viewer
DGNCT LLC
Dental AI
Segmentron Viewer is an FDA-cleared, AI-powered semi-automated software as a medical device (SaMD) for dental image processing and management, providing 3D segmentation and visualization of maxillofacial CBCT images for medical professionals.

What the Web Says

DGNCT (Diagnocat) is a healthcare IT company specializing in AI-powered dental diagnostic software. The product, Diagnocat, is an FDA-cleared platform that analyzes 2D and 3D dental images to detect various conditions and generate reports. Employer reviews for DGN Technologies (which appears to be a related entity or a previous name for the company) are generally positive, highlighting a good work culture and opportunities for growth. However, some employee reviews mention issues with management promises and H1B/PERM processing.

Overall: Mixed

Strengths

  • Comprehensive 2D and 3D radiographic AI analysis for dental images.
  • Detects over 65 conditions on CBCT scans and 35+ on panoramic and periapical X-rays.
  • FDA-cleared dental AI tool with dedicated CBCT segmentation capability.
  • Automated STL model generation from CBCT data for treatment planning.
  • Good work culture and supportive colleagues (employer review).
  • Opportunities for growth and learning (employer review).

Limitations

  • Lowest reliability observed in detecting caries, periapical lesions, voids in root canals, and overhangs in some studies.
  • Accuracy influenced by tooth location and imaging modality.
  • Limitations in detecting occlusal, labial, and lingual caries.
  • DGN management doesn't always keep promises (employer review).
  • High rejection rate for H1B and PERM processing (employer review).
  • Cost unclear until sales conversation (for a competitor, but implies similar for specialized AI dental tools).

Based on reviews from: Indeed.com, AI Dental Tools, The Molar Report, PubMed Central, MDPI

Last updated: 2026-07-20

Videos

News, demos, and interviews about DGNCT.

Loading videos...

Videos load interactively. If none appear, search YouTube for DGNCT →

View all on YouTube

Press & Coverage

accessdata.fda.gov
DGNCT, LLC FDA 510(k) Premarket Notification for Diagnocat
The FDA issued a 510(k) premarket notification for Diagnocat software, an AI-powered computer-assisted detection device intended to aid dental professionals in detecting periapical radiolucency on maxillofacial Cone Beam CT images. The device demonstrated strong agreement with reference standards in performance evaluations.
2026-01
MDPI
Application of AI-Driven Software Diagnocat in Managing Diagnostic Imaging in Dentistry: A Retrospective Study
This study investigates the diagnostic reliability of Diagnocat in detecting caries, dental restorations, missing teeth, and periodontal bone loss on panoramic radiographs, comparing its performance with evaluations from three independent dental experts. Diagnocat showed high overall sensitivity but low specificity, suggesting its promise as a screening tool.
2025-09
Diagnocat
It's official! Diagnocat is now FDA-cleared and available in the USA!
Diagnocat announced its official FDA clearance and availability in the USA, bringing its AI-powered CBCT visualization tool to American dental clinics. This milestone aims to simplify CBCT imaging, improve diagnostic accuracy, and enhance patient communication for dental professionals.
2025-10
accessdata.fda.gov
DGNCT, LLC FDA 510(k) Premarket Notification for Segmentron Viewer
The FDA issued a 510(k) premarket notification for DGNCT LLC's Segmentron Viewer, a software product intended for processing and manipulating maxillofacial radiographic images. Performance evaluations compared the software's segmentation and labeling against reference standards established by expert radiologists.
2025-09
ResearchGate
Evaluating Artificial Intelligence in Full-Arch CBCT Caries Detection: A Comparative Analysis with Clinical Assessment
This study aimed to compare the diagnostic accuracy of the Diagnocat system with clinical assessments performed by three dentists using cone-beam computed tomography (CBCT) data. The research focuses on the AI system's ability to detect caries.
2026-05
PMC
Diagnostic accuracy of an artificial intelligence-based software in detecting supernumerary and congenitally missing teeth in panoramic radiographs
This study evaluated the diagnostic accuracy of an AI-based software, Diagnocat, in detecting supernumerary and congenitally missing teeth in panoramic radiographs. The model showed strong agreement for congenitally missing teeth and moderate agreement for supernumerary teeth.
2025-07
The National Law Review
Connecticut Enacts New AI Rules for Employment Decisions
Connecticut has enacted new legislation, the 'Connecticut Artificial Intelligence Responsibility and Transparency Act,' regulating the use of artificial intelligence in employment decisions. The law imposes new obligations on employers using 'automated employment-related decision technology' in the state.
2026-06
HealthTech Magazines
Imaging Innovations Drive Personalized Radiation Therapy
This article discusses how imaging innovations, particularly with artificial intelligence, are driving personalized radiation therapy. It highlights the role of AI and medical imaging in transforming healthcare.
2026-07

Frequently Asked Questions

DGNCT, through its Diagnocat platform, offers AI-powered analysis of 2D and 3D dental images, including panoramic radiographs, intraoral images, and CBCT scans. It can detect over 60 tooth conditions in 3D and more than 40 in 2D images, aiding in the identification of caries, dental restorations, periodontal bone loss, and periapical lesions.
Diagnocat enhances diagnostic accuracy by providing an objective 'second opinion' and highlighting areas of concern on images, improving sensitivity in pathology detection. It facilitates patient education through intuitive 3D visualization and easy-to-understand radiological reports, which can motivate patients for treatment. The platform also streamlines treatment planning by offering detailed analyses and automatic segmentation of anatomical structures.
DGNCT's Diagnocat is FDA-cleared and compliant with HIPAA and SOC 2 standards, ensuring high levels of clinical and data security. The company is an actively registered establishment with the FDA as of 2026. It also adheres to relevant international and national standards and laws for medical product software.
DGNCT offers flexible pricing plans for Diagnocat, including '2D Practice' at 129 euros/month and '3D Practice' at 249 euros/month, with a comprehensive 'Contact Sales' option for larger needs. These plans include varying capacities for AI reports, cloud storage, and online support. Support requests can be initiated directly from the Diagnocat application or via email.
Diagnocat provides advanced 2D and 3D dental image processing, featuring automatic segmentation of teeth, pulp, and maxillofacial anatomical structures. It offers intuitive 3D visualization tools and MPR (Multiplanar Reconstruction) for detailed evaluation. The software also supports DICOM to STL conversion, allowing for the creation of 3D models.
DGNCT's Diagnocat is designed for versatility, working seamlessly with CBCT systems from leading global brands such as Sirona, Vatech, Planmeca, and Carestream. It also offers integration with practice management software (PMS) to provide seamless access to patient images and reports. The platform fosters collaboration among specialists and general practitioners by enabling easy sharing of patient files.
DGNCT LLC, based in Miami, Florida, maintains an active FDA registration status, indicating its operational stability in the medical device sector. The company is an award-winning solution and is actively pursuing future developments, including a sister company called Segmentron, focused on AI-driven treatment planning for orthodontics and implants.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.